Related Experiment Video

Updated: Jun 16, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

ROCK inhibitors as emerging therapeutic candidates for sarcomas

Stanislav Micuda1, Daniel Rösel, Ales Ryska

  • 1Department of Pharmacology, Charles University Faculty of Medicine, Hradec Kralove, Czech Republic.

Current Cancer Drug Targets
|January 22, 2010
PubMed

Insights

Targeting Rho/ROCK signaling effectively reduces sarcoma cell invasion and metastasis. This approach, using Rho-associated protein kinase (ROCK) inhibitors, shows promise for improving cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Sarcomas are aggressive tumors with high metastatic potential.
  • The Rho/ROCK signaling pathway is implicated in tumor cell invasion and metastasis.

Purpose of the Study:

  • To review the role of Rho/ROCK signaling in sarcoma invasion and metastasis.
  • To discuss the potential of Rho/ROCK inhibitors as anti-cancer therapeutics.

Main Methods:

  • Review of current pharmacological, biological, and pathological data.
  • In vitro and in vivo studies on Rho/ROCK pathway blockade.

Main Results:

  • Rho/ROCK pathway blockade decreases amoeboid tumor cell invasion in vitro.
  • Inhibition of Rho/ROCK signaling attenuates tumor growth and metastasis in vivo.

Conclusions:

  • Rho/ROCK dependent amoeboid invasion is crucial for sarcoma metastasis.
  • Targeting the Rho/ROCK pathway with inhibitors offers a promising strategy for sarcoma treatment.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...